NIH-funded research R01 grant

Understanding how adolescents can consent to HIV prevention research in Uganda

Official title: Improving understanding of Capacity to consent to sensitive biomedical HIV prevention Research among adolescents in Rakai Uganda (ICARE)

Funded at Graduate School of Public Health and Health Policy · NIH-11070363 · Data updated 2026-11-12

This study is looking at how teenagers in Rakai, Uganda can give their permission to join important HIV prevention research, while also understanding the challenges that getting permission from parents can create, and it aims to help make it easier for young people to take part in future studies about HIV prevention methods like PrEP.

More HIV Prevention research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGraduate School of Public Health and Health Policy
NIH-funded
Lab location1 site (New York, United States)
Project startApril 8, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$569,123
NIH project number5R01MH134695-02
Project IDNIH-11070363 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adolescents aged 12-20 living in Rakai, Uganda, who are interested in HIV prevention.

Less likely to help

Patients outside the age range of 12-20 or those not residing in Rakai, Uganda, may not benefit from this research.

What this research studies

This research focuses on the ability of adolescents in Rakai, Uganda, to provide informed consent for participation in sensitive biomedical HIV prevention research. It aims to identify the barriers that parental consent poses to adolescent involvement and to explore the developmental differences in decision-making among youth. By leveraging existing community cohort studies, the research will assess adolescents' beliefs and interests in HIV prevention methods like pre-exposure prophylaxis (PrEP). The ultimate goal is to create a digital toolkit that facilitates adolescent participation in future biomedical studies.

Why it matters

Potential benefit: If successful, this research could lead to increased participation of adolescents in HIV prevention trials, ultimately improving health outcomes in this vulnerable population.

How similar studies have gone: Previous research has shown that understanding consent capacity in adolescents can enhance their participation in sensitive health studies, indicating potential success for this approach.

Where this research is happening

  • Graduate School of Public Health and Health Policy
    New York, United States
    Active

Researchers

  • Principal investigator: Kreniske, Philip — Graduate School of Public Health and Health Policy
  • Study coordinator: Kreniske, Philip

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.